EN DE
STOCK COMPARISON

Rainbow Childrens Medicare vs HCA Healthcare: Fair Value & Quality

Both stocks run through our valuation models. Here is how Rainbow Childrens Medicare (RAINBOW) and HCA Healthcare (HCA) compare, as of Aug 18, 2026.

As of Aug 18, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Rainbow Childrens Medicare trades at ₹1,479 versus a fair value of ₹1,035 (-30%), while HCA Healthcare trades at $405 versus $548 (+35%).
Rainbow Childrens Medicare
RAINBOW.NSE · INR · Health Care
-30%
upside to fair value
overvalued
Price₹1,479
Fair Value₹1,035
Quality56/100
HCA Healthcare
HCA · USD · Health Care
+35%
upside to fair value
undervalued
Price$405
Fair Value$548
Quality70/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Rainbow Childrens MedicareHCA Healthcare
Valuation
53.9×P/E (TTM)14.0×
8.46×P/S (TTM)1.06×
8.75×P/B
26.4×EV/EBITDA7.8×
PEG1.18×
0.2%Dividend yield0.8%
Dividend per share$2.94
Profitability
16%Net margin9%
23%Operating margin15%
18%Return on equity136%
10%Return on assets12%
Growth
24%Revenue growth (YoY)4%
13.2%Avg. growth/yr (3Y)7.9%
21.2%Avg. growth/yr (5Y)8.0%
Balance & size
$2BMarket cap$81B
mixedGrowth qualityhealthy

HCA Healthcare leads: 5 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Rainbow Childrens Medicareof which business quality 55 · market factors 64 HCA Healthcareof which business quality 66 · market factors 38
ProfitabilityMargins and returns on capital today
56
76
Quality GrowthAre margins and returns improving?
49
61
CashflowEarnings quality: real cash, not paper profit
44
62
Fin. StrengthBalance sheet, leverage, solvency risk
66
39
InvestmentDisciplined investing over empire-building
27
75
Low VolatilityCalm price path (market factor)
92
59
MomentumPrice trend over the last 3–12 months (market factor)
53
26
52W MomentumDistance to the 52-week high (market factor)
49
36
Net IssuanceBuybacks instead of dilution
82
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Rainbow Childrens Medicare

DCF Models₹625
Earnings-Based₹423
Dividend Discount₹52.84
Multiples₹555
Asset-Based₹109
Growth DCF₹489
Economic Profit₹380
Growth Earnings₹646

26 of 26 models see the stock below the current price.

HCA Healthcare

DCF Models$546
Earnings-Based$289
Dividend Discount$53.85
Multiples$673
Growth DCF$540
Economic Profit$419
Growth Earnings$506

6 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Rainbow Childrens Medicare
Bear ₹528Fair Value ₹1,035Bull ₹1,332
₹1,479 = current price (white tick)
HCA Healthcare
Bear $260Fair Value $548Bull $841
$405 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Rainbow Childrens Medicare · Health Care

Quality score56 · above median
Fair value upside-30% · below median

HCA Healthcare · Health Care

Quality score70 · Top 25%
Fair value upside+35% · Top 25%

Bottom line

As of Aug 18, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Rainbow Childrens Medicare trades at ₹1,479 versus a fair value of ₹1,035 (-30%), while HCA Healthcare trades at $405 versus $548 (+35%).

HCA Healthcare has the higher quality score (70/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.